当前位置: 首页 > 期刊 > 《中国当代医药》 > 2014年第36期 > 正文
编号:12631024
普罗布考治疗非增生性糖尿病视网膜病变的效果评价(2)
http://www.100md.com 2014年12月25日 中国当代医药2014年第36期
     综上所述,普罗布考的不良反应较少,治疗过程安全,其机制可能与增强糖尿病视网膜病变患者的抗氧化应激状态有关,需进一步进行分子机制研究及临床应用推广。

    [参考文献]

    [1] Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.

    [2] Virag L,Szabó C.The therapeutic potential of poly(ADP-ribose)polymerase inhibitors[J].Pharmacol Rev,2002,54(3):375-429.

    [3] Obrosova IG,Pacher P,Szabo C,et al.Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose)polymerase activation in tissue sites for diabetes complications[J].Diabetes,2005,54(1):234-242.

    [4] Yokoi M,Yamagishi S,Takeuchi M,et al.Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy[J].Br J Ophthalmol,2005,89(6):673-675.

    [5] Du Y,Miller CM,KemTS.Hyperglycemia increases mi-tochondrial superoxide in retina and retinal cells[J].Free RadicBiol Med,2003,35(11):1491-1499.

    [6] Kowaltowski AJ,Castilho RF,Vercesi AE.Mitochondrial permeabilitytransition and oxidative stress[J].FEBS Lett,2001, 495(1/2):12-15.

    [7] Kern TS,Tang J,Mizutani M,et al.Response of capillary cell death to aminoguanidine predicts the development of retinopathy:comparison of diabetes and galactosemia[J].Invest Ophthalmol Vis Sci,2000,41(12):3972-3978.

    [8] Podesta F,Romeo G,Liu WH,et al.Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro[J].Am J Pathol,2000,156(3):1025-1032.

    [9] Mohr S,Tang J,Kern TS,et al.Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients[J].Diabetes,2002,51(4):1172-1179.

    [10] Romeo G,Liu WH,Asnaghi V,et al.Activation of nuclear factor-Kappa B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes[J].Diabetes,2002,51(7):2241-2248.

    [11] 陈永东,许讯.氧化应激在糖尿病视网膜病变中的作用研究进展[J].中华眼底病杂志,2007,23(4):298-300.

    [12] O′Leary VJ,TillingL,FleetwoodG,et al.The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy[J].Atherosclerosis,1996,119(2):169-179.

    [13] Bamhart RL,Busch SJ,Jackson RL.Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro:probucol degradation Precedes lipoprotein oxidation[J].J Lipid Res,1989,30(11):1703-1710.

    [14] Baumstark MW,Aristegui R,Zoller T,et al.Probucol,incorporated into LDL particles in vivo,inhibits generation of lipid peroxides more effectively than endogenous antioxidants alone[J].Clin Biochem,1992,25(5):395-397.

    [15] Masana L,Bargallo MT,Plana N,et al.Effeetiveness of pro-bucolinreducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia[J].Am J Cardiol,1991,68(9):863-867.

    [16] 刘庆淮,谢平,戈应滨,等.一氧化氮及其合成酶在糖尿病视网膜损伤中的作用[J].中华眼科杂志,2005,41(9):837-841.

    (收稿日期:2014-09-12 本文编辑:李亚聪) (蒋苏平)
上一页1 2